What is Oneleaf?
Founded in 2022, Oneleaf operates at the intersection of behavioral science and digital health. The company specializes in self-hypnosis applications designed to facilitate stress reduction, habit formation, and cognitive wellness. By digitizing traditional therapeutic techniques, Oneleaf provides a scalable, accessible alternative to conventional wellness coaching. Its market position is bolstered by a strong focus on user-centric design and evidence-based methodologies, allowing it to capture a growing demographic of consumers seeking autonomous mental health tools. As a French startup, Oneleaf benefits from a robust local ecosystem that supports high-growth technology ventures, enabling it to compete effectively in the global wellness technology landscape.
How much funding has Oneleaf raised?
Oneleaf has raised a total of $5.1M across 1 funding round:
Other Financing Round
$5.1M
Other Financing Round (2023): $5.1M with participation from Frst, Raise Ventures, and Kima Ventures
Key Investors in Oneleaf
Frst
Frst Capital is a seed-stage venture firm focused on supporting French entrepreneurs. Frst Capital was founded in 2019 and is headquartered in France.
Raise Ventures
The RAISE Accelerator is a 6 month intensive programme. Our startups will work with the Raise team to build strong foundations for their business with the aim to innovate, validate, accelerate and raise investment.
Kima Ventures
Kima Ventures is the venture capital arm of Xavier Niel, one of the most active early-stage investors in the world. Kima is investing in 100 startups per year from pre-seed to seed.
What's next for Oneleaf?
With the successful closure of this major enterprise-level funding, Oneleaf is poised to transition from its initial development phase into a period of aggressive market expansion. The strategic roadmap likely includes enhancing its algorithmic capabilities to offer more personalized user experiences and expanding its reach into international markets. Furthermore, the company is expected to invest in clinical validation studies to solidify its credibility within the broader digital health industry. By maintaining its focus on scalable self-hypnosis solutions, Oneleaf is well-positioned to capitalize on the increasing demand for digital mental health interventions, ensuring long-term sustainability and competitive differentiation in a crowded wellness market.
See full Oneleaf company page
